Completed
Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia
NCT05171751
- Conditions
- Congenital Hyperinsulinaemic Hypoglycaemia, Octreotide Adverse Reaction
- Locations
-
- Department of Endocrinology, Genetics, Metabolism Beijing, Beijing Municipality, China